首都医科大学学报 ›› 2010, Vol. 31 ›› Issue (1): 1-3.

• 奖项介绍 • 上一篇    下一篇

呼吸衰竭的发病机理与治疗研究——2009年度国家科学技术进步二等奖

任雁宏, 詹庆元   

  1. 首都医科大学附属北京朝阳医院, 北京市呼吸疾病研究所
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2010-02-21 发布日期:2010-02-21

The Second Grade National Prize for Science and Technology Progress——Studies on Pathogenesis and Treatment of Respiratory Failure

REN Yan-hong, ZHAN Qing-yuan   

  1. Beijing Institute of Respiratory Medicine, Beijing Chaoyang Hospital, Capital Medical University
  • Received:1900-01-01 Revised:1900-01-01 Online:2010-02-21 Published:2010-02-21

摘要:

针对我国在呼吸衰竭救治方面曾长期处于落后状态,本项目从呼吸衰竭发病中的关键环节,治疗呼吸衰竭的关键技术、方法与治疗策略,进行了系统地研究,作出了重要的科技创新:提出“肺部感染控制窗”的概念,并创立有创无创序贯通气疗法;提出针对呼吸肌疲劳和呼吸功能不全的无创正压通气(NPPV)治疗新观念;研发并生产出具有自主知识产权的3种新型无创通气面罩;创制具有气道动态萎陷特性的肺模型,证实内源性呼气末正压(PEEPi)导致慢性阻塞性肺疾病(COPD)患者呼吸困难的作用途径;最早在国内建立系统的膈肌肌力和耐力测定方法;证实水通道蛋白1(AQP1,Aquaporin 1)是肺内液体转运的关键调控点;以前瞻性表明发现抑郁可显著增加COPD急性加重风险;主持制定我国第一部《无创正压通气临床应用中的几点建议》和《AECOPD的机械通气指南》。以多种形式积极推广研究成果,从整体上提高了我国在该领域的治疗与研究水平。

关键词: 呼吸衰竭, 人工通气, 无创正压通气, 水通道, 肺疾病, 阻塞性, 肺损伤

Abstract:

To improve the status of management in respiratory failure in China, the project of Studies on Pathogenesis and Treatment of Respiratory Failure was designed and conducted by three medical centers(Beijing Institute of Respiratory Medicine, Beijing Chaoyang Hospital, Affiliate of Capital Medical University; Zhongshan HospitalFudan University; and Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical College) for more than ten years. This project focused on pathogenesis and treatment strategies of respiratory failure and achieved the following important innovations: (1) Pulmonary Infection Control Window(PIC Window) was firstly proposed and be used to determine the time switching point of sequential invasive-noninvasive ventilation; (2) The largest sample size of early use of noninvasive positive pressure ventilation(NPPV) for acute exacerbated COPD(AECOPD) on general ward provided the evidence-based data for expanding the indication of NPPV from treating respiratory failure to alleviating respiratory muscle fatigue; (3)Three new type masks with intellectual property for NPPV were developed; (4) By designing intrinsic expiratory end positive pressure(PEEPi) lung model with property of expiratory flow limitation, PEEPi was confirmed to be the most important factor to increase inspiratory difficulty; (5) The systematic measuring method of the diaphragm strength and endurance was established; (6) We firstly confirmed that aquaporin 1 (AQP1) was the key channel of fluid transportation in the lung; (7) A multicenter prospective cohort study provided objective data that depression has causal effect on COPD exacerbations and hospitalization; (8) The two guidelines for NPPV and mechanical ventilation of AECOPD were initiated by this group. This project has been acquired widespread use in clinical practice and promoted the research and treatment of respiratory failure in China.

Key words: respiratory failure, artificial ventilation, noninvasive positive pressure ventilation, aquaporin, pulmonary disease, obstructive, lung injury

中图分类号: